GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report)’s share price was up 40.4% on Thursday . The stock traded as high as $0.18 and last traded at $0.17. Approximately 7,345 shares were traded during trading, a decline of 55% from the average daily volume of 16,415 shares. The stock had previously closed at $0.12.
GeoVax Labs Stock Performance
The stock has a 50-day moving average price of $0.11 and a 200-day moving average price of $0.16.
GeoVax Labs Company Profile
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Featured Stories
- Five stocks we like better than GeoVax Labs
- What is a Death Cross in Stocks?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Insider Buying Explained: What Investors Need to Know
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
